Intelligenescan Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Intelligenescan General Information

Description

Operator of a biotechnology company focused on disease diagnostics using gene expression analysis. The company specializes in the development and commercialization of colon cancer diagnostic tests, enabling user to detect colon cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Corporate Office
  • 3702 Autumn Glen Court
  • Santa Rosa, CA 95403
  • United States
+1 (707)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 3702 Autumn Glen Court
  • Santa Rosa, CA 95403
  • United States
+1 (707)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intelligenescan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Aug-2021 Completed Generating Revenue
3. Angel (individual) 13-Jul-2010 Completed Generating Revenue
2. Angel (individual) 28-Nov-2008 $50K $580K Completed Generating Revenue
1. Angel (individual) 06-Oct-2006 $530K $530K Completed Startup
To view Intelligenescan’s complete valuation and funding history, request access »

Intelligenescan Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Intelligenescan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2010257379-A1 Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods and kits thereof Inactive 30-Sep-2004
CA-2580528-A1 Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods and kits thereof Inactive 30-Sep-2004
AU-2005292025-A1 Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods and kits thereof Inactive 30-Sep-2004
EP-1794318-A2 Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods and kits thereof Inactive 30-Sep-2004
EP-1794318-A4 Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods and kits thereof Inactive 30-Sep-2004 C12Q1/6886
To view Intelligenescan’s complete patent history, request access »

Intelligenescan Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
North Bay Angels Angel Group Minority
To view Intelligenescan’s complete investors history, request access »

Ready to get started?

Request a free trial

Intelligenescan FAQs

  • When was Intelligenescan founded?

    Intelligenescan was founded in 2006.

  • Where is Intelligenescan headquartered?

    Intelligenescan is headquartered in Santa Rosa, CA.

  • What industry is Intelligenescan in?

    Intelligenescan’s primary industry is Biotechnology.

  • Is Intelligenescan a private or public company?

    Intelligenescan is a Private company.

  • What is Intelligenescan’s current revenue?

    The current revenue for Intelligenescan is .

  • How much funding has Intelligenescan raised over time?

    Intelligenescan has raised $680K.

  • Who are Intelligenescan’s investors?

    North Bay Angels has invested in Intelligenescan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »